Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:ABBV
AbbVie
|
159.62 | -19.74% | -9.12% | 282,630.67 | 3.88% | 7.03% |
|
NasdaqGS:AMGN
Amgen
|
269.98 | 1.55% | 11.74% | 144,810.67 | 3.33% | 5.31% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
65.42 | 25.22% | 34.84% | 81,576.73 | 4.71% | 0.15% |
|
NasdaqGM:ALXN
Alexion Pharmaceuticals
|
182.50 | 0% | 0% | 40,336.01 | 0% | 0% |
|
NasdaqGS:BIIB
Biogen
|
208.90 | -3.23% | 13.94% | 29,361.43 | 0% | -10.89% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
80.91 | 142.56% | 222.09% | 15,363.17 | 0% | 32.46% |
|
NasdaqGS:INCY
Incyte
|
51.68 | 108.8% | 158.21% | 11,753.94 | 0% | 27.98% |
|
NasdaqCM:VKTX
Viking Therapeutics
|
74.31 | 0% | 0% | 8,194.03 | 0% | 0% |
|
NasdaqGM:ARNA
Arena Pharmaceuticals
|
99.99 | 0% | 0% | 6,165.32 | 0% | 0% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
93.00 | 0% | 0% | 5,526.83 | 0% | 0% |
|
NasdaqGM:FOLD
Amicus Therapeutics
|
10.28 | 0% | 0% | 3,797.68 | 0% | 0% |
|
NasdaqGS:CCXI
ChemoCentryx
|
51.99 | 0% | 0% | 3,739.11 | 0% | 0% |
|
NasdaqGS:CBAY
CymaBay Therapeutics
|
32.44 | 0% | 0% | 3,724.47 | 0% | 0% |
|
NasdaqGM:IOVA
Iovance Biotherapeutics
|
11.64 | 0% | 0% | 3,158.96 | 0% | 0% |
|
NasdaqGM:DRNA
Dicerna Pharmaceuticals
|
38.01 | 0% | 0% | 2,986.1 | 0% | 0% |
|
NasdaqGS:ACAD
ACADIA Pharmaceuticals
|
16.71 | 0% | 0% | 2,771.46 | 0% | 0% |
|
NasdaqGS:ARWR
Arrowhead Pharmaceuticals
|
22.12 | 0% | 0% | 2,766.62 | 0% | 0% |
|
NasdaqCM:CLDX
Celldex Therapeutics
|
36.30 | 0% | 0% | 2,446.7 | 0% | 0% |
|
NasdaqGM:VCEL
Vericel
|
46.05 | -94.44% | -74.6% | 2,180.06 | 0% | 0% |
|
NasdaqGM:ARDX
Ardelyx
|
6.42 | 0% | 0% | 2,173.29 | 0% | 0% |
